Tally HealthTM, a revolutionary consumer biotechnology company that aims to change the way we age, today announced a $10 million seed round. Tally Health’s proprietary and science-based tools, such as TallyAgeTM epigenetic age tests, personalized lifestyle recommendations, and research-backed longevity supplements, aim to improve healthspan and extend longevity at the cellular level.
Dr. David Sinclair, one of the world’s foremost experts on aging and human longevity, and L Catterton Partner and serial entrepreneur Whitney Casey co-founded Tally Health, which launched in late February.
Forerunner Ventures led the seed round, with participation from L Catterton, which incubated and initially backed the company, as well as G9 Ventures and Second Sight Ventures.
With this investment, Kirsten Green, Founding Partner of Forerunner Ventures, will join the Tally Health Board of Directors, which will become a majority female board with Kirsten’s addition.
Furthermore, celebrities such as John Legend, Chrissy Teigen, Pedro Pascal, Shonda Rhimes, Kevin Hart, Rich Roll, Whitney Cummings, and Zac Efron have made individual investments in the company.
Tally Health will use the new funds to expand research and development of new products, features, and technology integrations that will allow users to seamlessly integrate their TallyAgeTM feedback into their daily lifestyle via the digital member experience.
As the company grows, funds will be allocated to various technical, business, and strategic development efforts.Tally HealthTM is a consumer biotechnology company that was founded to revolutionize the way we age.
Tally Health’s proprietary diagnostic test and individualized interventions, co-founded by Dr. David Sinclair, who is also a scientific advisor, provide members with science-backed tools to live healthier, longer lives. Tally Health was incubated and is backed by L Catterton, the largest global consumer-focused private equity firm.
